Biological
AMG 714
AMG 714 is a biological therapy with 6 clinical trials. Historical success rate of 100.0%.
Total Trials
6
Max Phase
—
Type
BIOLOGICAL
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 5 completed trials
Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
60%(3 trials)
Phase Distribution
Ph phase_2
5
83%
Phase Distribution
0
Early Stage
5
Mid Stage
0
Late Stage
Phase Distribution5 total trials
Phase 2Efficacy & side effects
5(100.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
5 of 5 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
6
all time
Status Distribution
Completed(5)
Other(1)
Detailed Status
Completed5
unknown1
Development Timeline
Analytics
Development Status
Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 25 (100.0%)
Trials by Status
completed583%
unknown117%
Recent Activity
0 active trials
Showing 5 of 6
completedphase_2
Evaluation of AMG 714 for Vitiligo
NCT04338581
unknown
AMG 714 Expanded Access Program
NCT03439475
completedphase_2
Study to Evaluate the Efficacy and Safety of AMG 714 in Adult Patients With Type II Refractory Celiac Disease
NCT02633020
completedphase_2
A Study to Evaluate the Efficacy and Safety of AMG 714 in Adult Patients With Celiac Disease
NCT02637141
completedphase_2
AMG 714 20060349 Multiple Dose Study in Moderate to Severe Psoriasis Subjects
NCT00443326
Clinical Trials (6)
Showing 6 of 6 trials
NCT04338581Phase 2
Evaluation of AMG 714 for Vitiligo
NCT03439475
AMG 714 Expanded Access Program
NCT02633020Phase 2
Study to Evaluate the Efficacy and Safety of AMG 714 in Adult Patients With Type II Refractory Celiac Disease
NCT02637141Phase 2
A Study to Evaluate the Efficacy and Safety of AMG 714 in Adult Patients With Celiac Disease
NCT00443326Phase 2
AMG 714 20060349 Multiple Dose Study in Moderate to Severe Psoriasis Subjects
NCT00433875Phase 2
Phase 2 AMG 714 in Rheumatoid Arthritis
All 6 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 6